Menu

S. Benghiat MD, PhD

Articles

PP4.2 The clinical relevance of imatinib (Im) plasma trough concentration in patients with chronic myelocytic leukemia (CML) in chronic phase. A Belgian retrospective study

BJH - volume 7, issue Abstract Book BHS, january 2016

F. Van Obbergh MD, L. Knoops MD, PhD, Y. Beguin MD, PhD, C. Graux MD, PhD, S. Benghiat MD, PhD, K. Kargar-Samani , D. Bauwens , A. Efira MD, C. Dubois , C. Springael MD, PhD, L. Montfort , T. Connerotte , A. Delannoy , P. Wallemacq

Read more

P1.14 Monoclonal B-cell lymphocytosis (MBL): results of a routine screening in a general hospital

BJH - volume 6, issue Abstract Book BHS, january 2015

G. Claes , D. Bron MD, PhD, M. Maerevoet MD, S. Benghiat MD, PhD, V. De Wilde MD, PhD, B. Bailly MD, N. Istaces , J. Brauner , O. Pradier MD, PhD, N. Meuleman MD, PhD

Read more

Disease characteristics in Belgian myelofibrosis patients and management guidelines anno 2013

BJH - volume 4, issue 4, december 2013

T. Devos MD, PhD, N. Straetmans MD, PhD, C. Schuermans MD, S. Benghiat MD, PhD, V. Robin MD, P. Lewalle MD, PhD, P. Mineur MD, G. Verhoef MD, PhD, L. Knoops MD, PhD

Summary

Diagnostic and management guidelines for myelofibrosis patients are presented in this paper. As a consequence of the rapid evolution and progress in this domain over the last years, the need was felt by the BHS MPN subcommittee to update these guidelines for our country. The different prognostic scores in myelofibrosis, the diagnostic tools and treatment options with the focus on new possibilities are discussed.

(BELG J HEMATOL 2013;4(4): 127–137)

Read more
Top